Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Synthetic Biologics, Inc.

AMEX: SYNHealthcare / Biotechnology / USA
0.70+0.03+4.48%Vol 296 0081Y Perf -96.53%
Dec 10th, 2018 14:51
BID0.70 ASK0.70
Open0.67 Previous Close0.68
Pre-Market0.70 After-Trading0.70
 0.02 2.94%  0.03 4.48%
Target Price
6.00 
Analyst Rating
Strong Buy 1.00
Potencial %
769.57 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)9 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
0.25 
Earnings Date
8th Nov 2018

Today's Price Range

0.650.70

 

52wk Range

0.6521.00

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Month
-26.37%
3 Months
-74.62%
6 Months
-91.30%
1 Year
-96.53%
3 Years
-99.30%
5 Years
-98.44%

Quotes

Name / TickerPriceChg.Chg.%
SYN0.700.03004.48
AAPL169.040.55000.33
GOOG1 042.105.52000.53
MSFT106.852.03001.94
XOM75.85-1.7900-2.31
WFC48.78-1.4800-2.94
JNJ145.00-0.4300-0.30
FB141.814.39003.19
GE6.91-0.1000-1.43
JPM101.12-2.1700-2.10
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
2.50
Current Ratio
2.60
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-
Leverage Ratio -3.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
21.96
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-0.60
Cash Flow Per Share
-3.35
Price to Tangible Book
-2.75
Book Value per Share
-0.28
Enterprise Value (in ths.)
700
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-248.23
ROE last 12 Months
73.96
Return on Assets (5Y Avg)
-147.00
ROA last 12 Months
-44.53
Return on Capital (5Y Avg)
-549.91
ROC last 12 Months
-115.04
Return on invested Capital Q
-115.04
Return on invested Capital Y
-1 886.50
Assets Turnover
0.00
Receivables Turnover
0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-1.32-0.9329.55
Q02 2018-1.40-1.0525.00
Q01 2018-1.75-0.7060.00
Q04 2017-1.750.70140.00
Q03 2017-1.75-4.90-180.00
Q02 2017-2.45-1.0557.14
Q01 2017-0.07-0.0271.43
Q04 2016-0.09-0.0277.78
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.2580.47Positive
12/2018 FY-2.3648.25Positive
3/2019 QR-0.1688.57Positive
12/2019 FY-0.8480.87Positive
Next Report Date-
Estimated EPS Next Report-1.32
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume296 008
Shares Outstanding (in ths.)13 480
Trades Count523
Dollar Volume177 919
Avg. Volume331 051
Avg. Weekly Volume210 715
Avg. Monthly Volume502 649
Avg. Quarterly Volume1 138 977

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

73%27%

Bearish Bullish

37%63%

Bearish Bullish

64%36%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News